These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 7514177)

  • 1. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
    Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
    J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3.
    Carraway KL; Soltoff SP; Diamonti AJ; Cantley LC
    J Biol Chem; 1995 Mar; 270(13):7111-6. PubMed ID: 7535767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85.
    Gamett DC; Greene T; Wagreich AR; Kim HH; Koland JG; Cerione RA
    J Biol Chem; 1995 Aug; 270(32):19022-7. PubMed ID: 7642563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
    Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
    FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase.
    Vijapurkar U; Cheng K; Koland JG
    J Biol Chem; 1998 Aug; 273(33):20996-1002. PubMed ID: 9694850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The erbB3 gene product is a receptor for heregulin.
    Carraway KL; Sliwkowski MX; Akita R; Platko JV; Guy PM; Nuijens A; Diamonti AJ; Vandlen RL; Cantley LC; Cerione RA
    J Biol Chem; 1994 May; 269(19):14303-6. PubMed ID: 8188716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
    Fiddes RJ; Janes PW; Sanderson GM; Sivertsen SP; Sutherland RL; Daly RJ
    Cell Growth Differ; 1995 Dec; 6(12):1567-77. PubMed ID: 9019162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes.
    Carver RS; Sliwkowski MX; Sitaric S; Russell WE
    J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
    Chan SD; Antoniucci DM; Fok KS; Alajoki ML; Harkins RN; Thompson SA; Wada HG
    J Biol Chem; 1995 Sep; 270(38):22608-13. PubMed ID: 7673253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.
    Kim HH; Vijapurkar U; Hellyer NJ; Bravo D; Koland JG
    Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):189-95. PubMed ID: 9693119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt-mediated survival of oligodendrocytes induced by neuregulins.
    Flores AI; Mallon BS; Matsui T; Ogawa W; Rosenzweig A; Okamoto T; Macklin WB
    J Neurosci; 2000 Oct; 20(20):7622-30. PubMed ID: 11027222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3.
    Vartanian T; Goodearl A; Viehöver A; Fischbach G
    J Cell Biol; 1997 Apr; 137(1):211-20. PubMed ID: 9105049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
    Jackson JG; St Clair P; Sliwkowski MX; Brattain MG
    Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
    Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDF/heregulin stimulates the phosphorylation of Her3/erbB3.
    Kita YA; Barff J; Luo Y; Wen D; Brankow D; Hu S; Liu N; Prigent SA; Gullick WJ; Nicolson M
    FEBS Lett; 1994 Jul; 349(1):139-43. PubMed ID: 8045292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate.
    Altiok N; Bessereau JL; Changeux JP
    EMBO J; 1995 Sep; 14(17):4258-66. PubMed ID: 7556067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. II. Comparison of phorbol ester and sphingomyelinase-induced phosphorylation of ErbB2 and ErbB3.
    Emkey R; Kahn CR
    J Biol Chem; 1997 Dec; 272(49):31182-9. PubMed ID: 9388272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
    Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
    Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.